Last reviewed · How we verify
Acute bacterial skin and skin structure infections
Approved treatments
- Ceftaroline Fosamil · Abbvie
Ceftaroline works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute bacterial skin and skin structure infections patent landscape — cliff calendar, originator estates, attackable patents
- Acute bacterial skin and skin structure infections treatment landscape brief
- Acute bacterial skin and skin structure infections treatment updates RSS
Frequently asked questions about Acute bacterial skin and skin structure infections
What drugs treat Acute bacterial skin and skin structure infections?
Tracked treatments include Ceftaroline Fosamil.
What is the treatment for Acute bacterial skin and skin structure infections?
Standard treatment for Acute bacterial skin and skin structure infections includes Ceftaroline Fosamil. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute bacterial skin and skin structure infections patent cliff · Acute bacterial skin and skin structure infections CI report
- Treatment: Ceftaroline Fosamil · Abbvie
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing